BWX Technologies (BWXT) falls after Q1 beat as investors weigh backlog conversion

BWX Technologies shares fell after the company’s first-quarter 2026 revenue and non-GAAP earnings topped Wall Street estimates, with management citing stronger throughput, work pacing and demand across government and commercial nuclear markets. The stock traded at $205.49 after the report, down from $216.68 before the earnings release, implying a decline of about 5.2%. CEO Rex Geveden said performance was supported by improved manufacturing throughput and operational execution. Management also pointed to a significant year-over-year increase in backlog, saying it improves visibility into future growth. Investors are focused on BWXT’s U.S. manufacturing expansion, including progress at its Mount Vernon facility and integration of PCG, as well as the pace at which backlog converts into revenue. Additional areas of scrutiny include advanced nuclear fuel, medical isotopes and demand for localized nuclear supply chains.